The Victorian Supreme Court recently dismissed a class action on behalf of more than 1,400 women who received Bayer's Essure contraceptive device. The decision attracted significant publicity, ...

Please provide your email address to receive an email when new articles are posted on . Ovaprene, a monthly hormone-free contraceptive, blocked motile sperm in an early-phase study. There were no ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Venova Technologies, Inc., a women-led startup developing a novel long-acting, hormone-free and copper-free female birth control device, has been awarded a $2.23M ...

A Georgia federal judge on Monday reportedly denied Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) a request to delay the first trial in thousands of lawsuits alleging its Paragard intrauterine ...

In a “unique type of restriction,” the US Food and Drug Administration (FDA) issued an order Monday to limit sales and distribution of Bayer’s permanent contraception device, Essure, over the numerous ...

Canadian drug and device regulator Health Canada on Monday said it is working with Bayer to develop better risk communication for the permanent birth control device Essure after a safety review of the ...

Why should women in British Columbia, Manitoba, Prince Edward Island and the Yukon have access to free contraception while the rest of Canadians do not? Our new research, published in the British ...

According to new studies, iPhone may be the culprit of the declining birth rates. Research hints that the Apple's smartphone ...